Uncategorized
Novartis appoints Mike Ball to lead Alcon, announces business changes for 2016
Novartis has appointed Mike Ball as division head and CEO of Alcon, effective Feb. 1. He will succeed Jeff George.“I want to welcome Mike Ball as division head and CEO of Alcon. His expertise in ophthalmology, as well as medical devices, will be instrumental in accelerating innovation and growth at Alcon,” Joseph Jimenez, CEO of Novartis, said in a press release.